Pancuronium and Coronary artery bypass - a phase IV clinical study of FDA data

Summary:

Coronary artery bypass is reported as a side effect among people who take Pancuronium (pancuronium bromide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Arava, and have Asthma.

The phase IV clinical study analyzes which people have Coronary artery bypass when taking Pancuronium. It is created by eHealthMe based on reports of 1,327 people who have side effects when taking Pancuronium from the FDA, and is updated regularly.

What is Pancuronium?

Pancuronium has active ingredients of pancuronium bromide. eHealthMe is studying from 1,328 Pancuronium users. Check the latest studies of Pancuronium.

What is Coronary artery bypass?

Coronary artery bypass is found to be associated with 393 drugs and 486 conditions by eHealthMe. Check the latest studies of Coronary artery bypass.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

1,327 people reported to have side effects when taking Pancuronium.
Among them, 21 people (1.58%) have Coronary artery bypass.

Could Pancuronium cause Coronary artery bypass?

Among these 21 people:

How long have people been on Pancuronium when they have Coronary artery bypass? *

What is the gender of people who have Coronary artery bypass when taking Pancuronium? *

female: 100 %
male: 0.0 %

What is the age of people who have Coronary artery bypass when taking Pancuronium? *

What are other drugs people take besides Pancuronium? *

What are other side effects people have besides Coronary artery bypass? *

Renal Impairment (severely reduced kidney function): 21 people, 100.00%
Hepatocellular Injury (liver injury): 21 people, 100.00%
Acute Kidney Failure: 21 people, 100.00%
Bleeding Disorders: 21 people, 100.00%
Gastric Ulcer (stomach ulcer): 21 people, 100.00%
Hepatic Ischaemia (liver does not get enough blood or oxygen, causing injury to liver cells): 21 people, 100.00%
Haematemesis (vomiting of blood): 21 people, 100.00%
Hepatorenal Syndrome (renal failure in patients with advanced chronic liver disease): 21 people, 100.00%
Hypovolaemia (a decreased volume of circulating blood in the body): 21 people, 100.00%
Labile Blood Pressure (wildly fluctuating blood pressure): 21 people, 100.00%

What are the existing conditions these people have? *

Stable Angina (a constant chest pain): 21 people, 100.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 21 people, 100.00%
Muscle Spasms (muscle contraction): 21 people, 100.00%
High Blood Pressure: 21 people, 100.00%
High Blood Cholesterol: 21 people, 100.00%
Asthma: 21 people, 100.00%
Anaesthesia: 19 people, 90.48%
Gastric Ulcer (stomach ulcer): 17 people, 80.95%
Hepatorenal Syndrome (renal failure in patients with advanced chronic liver disease): 7 people, 33.33%
Pain: 4 people, 19.05%

* Approximation only. Some reports may have incomplete information.

Do you take Pancuronium and have Coronary artery bypass?

- Check whether Coronary artery bypass is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pancuronium:

Pancuronium (1,328 reports)

Browse all side effects of Pancuronium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Coronary artery bypass:

Coronary artery bypass (393 drugs)

Browse all the conditions that are associated with Coronary artery bypass:

Coronary artery bypass (486 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pancuronium bromide (the active ingredients of Pancuronium) and Pancuronium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.